Kosaka Mayu, Takahashi Naoto, Saitoh Hirobumi, Masai Rie, Ito Mitsugu, Sato Ryuta, Wakui Hideki, Sawada Kenichi
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan.
Intern Med. 2011;50(5):487-93. doi: 10.2169/internalmedicine.50.4300. Epub 2011 Mar 1.
A 26-year-old woman with a history of mild mental retardation, Charcot-Marie-Tooth disease (CMT) and idiopathic thrombocytopenic purpura developed severe thrombocytopenia with Coombs-negative hemolytic anemia. Magnetic resonance imaging revealed a fresh cerebral infarction in the left precentral gyrus. ADAMTS-13 deficiency caused by an inhibitor and anti-cardiolipin antibodies were detected in the blood. After treatment with prednisolone and fresh frozen plasma, ADAMTS-13 activity was normalized, the ADAMTS-13 inhibitor had disappeared and the thrombocytopenia with a bleeding tendency was improved. To our knowledge, this is the first case of thrombotic thrombocytopenic purpura caused by ADAMTS-13 deficiency associated with antiphospholipid antibodies and CMT.
一名26岁女性,有轻度智力发育迟缓、夏科-马里-图斯病(CMT)和特发性血小板减少性紫癜病史,出现严重血小板减少伴库姆斯阴性溶血性贫血。磁共振成像显示左侧中央前回有新发脑梗死。血液中检测到由抑制剂和抗心磷脂抗体引起的ADAMTS-13缺乏。经泼尼松龙和新鲜冰冻血浆治疗后,ADAMTS-13活性恢复正常,ADAMTS-13抑制剂消失,伴有出血倾向的血小板减少症得到改善。据我们所知,这是首例由ADAMTS-13缺乏与抗磷脂抗体及CMT相关引起的血栓性血小板减少性紫癜病例。